These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10780585)

  • 21. Nonerosive reflux disease.
    Waring JP
    Semin Gastrointest Dis; 2001 Jan; 12(1):33-7. PubMed ID: 11215854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?
    Tack J; Koek G; Demedts I; Sifrim D; Janssens J
    Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastroesophageal reflux disease: pathophysiology and pharmacology overview.
    Dajani EZ
    J Assoc Acad Minor Phys; 2000; 11(1):7-11. PubMed ID: 10826019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. pH 4.0.
    Fossmark R; Brenna E; Waldum HL
    Scand J Gastroenterol; 2007 Mar; 42(3):297-8. PubMed ID: 17354107
    [No Abstract]   [Full Text] [Related]  

  • 25. Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD.
    Katz PO
    Rev Gastroenterol Disord; 2006; 6(3):136-45. PubMed ID: 16957654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Precise role of acid in non-erosive reflux disease.
    Wang C; Hunt RH
    Digestion; 2008; 78 Suppl 1():31-41. PubMed ID: 18832838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On-demand therapy for gastro-oesophageal reflux disease.
    Bytzer P
    Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S19-22. PubMed ID: 11430504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
    Delaney B; McColl K
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():32-40. PubMed ID: 16042657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Characteristics of gastric secretory and motor functions in gastroesophageal reflux disease with constipations].
    Lychkova AE; Ianova OB; Masharova AA
    Eksp Klin Gastroenterol; 2008; (4):25-7. PubMed ID: 19148992
    [No Abstract]   [Full Text] [Related]  

  • 30. [Current concepts in therapy of reflux disease].
    Kirchgatterer A; Aschl G; Hinterreiter M; Stadler B; Knoflach P
    Wien Med Wochenschr; 2001; 151(11-12):266-9. PubMed ID: 11515224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton pump inhibition. An effective, safe approach to GERD management.
    Berardi RR
    Postgrad Med; 2001 Oct; Spec No():24-35. PubMed ID: 11868428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acid-related disorders and use of antisecretory medication.
    Lassen AT
    Dan Med Bull; 2007 Feb; 54(1):18-30. PubMed ID: 17349216
    [No Abstract]   [Full Text] [Related]  

  • 33. Management strategies for gastroesophageal reflux disease.
    Bak YT
    J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S49-53. PubMed ID: 15324382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between gastric pH and gastro-oesophageal reflux contents: ambulatory pH-impedance monitoring results.
    Roman S; Serraj I; Damon H; Mion F
    Neurogastroenterol Motil; 2007 Jul; 19(7):562-8. PubMed ID: 17593137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in proton pump inhibitors and management of acid-peptic disorders.
    Jain KS; Shah AK; Bariwal J; Shelke SM; Kale AP; Jagtap JR; Bhosale AV
    Bioorg Med Chem; 2007 Feb; 15(3):1181-205. PubMed ID: 17150362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological targets in gastro-oesophageal reflux disease.
    Piche T; Galmiche JP
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):333-41. PubMed ID: 16364047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicobacter pylori seropositivity predicts outcomes of acid suppression therapy for laryngopharyngeal reflux symptoms.
    Oridate N; Takeda H; Yamamoto J; Asaka M; Mesuda Y; Nishizawa N; Mori M; Furuta Y; Fukuda S
    Laryngoscope; 2006 Apr; 116(4):547-53. PubMed ID: 16585857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton pump inhibitor failure in gastro-oesophageal reflux disease--what about eosinophilic oesophagitis?
    Sgouros SN; Mantides A
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1281; author reply 1282-3. PubMed ID: 16611296
    [No Abstract]   [Full Text] [Related]  

  • 39. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Introduction: the scientific and clinical rationale for extended acid suppression.
    Katz PO
    Aliment Pharmacol Ther; 2006 Jun; 23 Suppl 2():1. PubMed ID: 16700897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.